Apa yang Perlu Diketahui tentang Donanemab Eli Lilly saat FDA Mempertimbangkan Persetujuan
Toplne A panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s experimental Alzheimer’s drug donanemab for FDA approval, a closely watched decision that could pave the way for the drug to become the second of its kind authorized in the U.S.. Experts are weighing up donanemab, Eli Lilly’s Alzheimer’s … Baca Selengkapnya